# Effects of Water and Food Intake on the Pharmacokinetics and Pharmacodynamics of Oral Salmon Calcitonin in Healthy Postmenopausal Women

> **NCT00395395** · PHASE1 · COMPLETED · sponsor: **Novartis** · enrollment: 56 (estimated)

## Conditions studied

- Postmenopausal Osteoporosis

## Interventions

- **DRUG:** Oral salmon calcitonin, salmon calcitonin nasal spray

## Key facts

- **NCT ID:** NCT00395395
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-10
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 56 (ESTIMATED)
- **Last updated:** 2007-05-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00395395

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00395395, "Effects of Water and Food Intake on the Pharmacokinetics and Pharmacodynamics of Oral Salmon Calcitonin in Healthy Postmenopausal Women". Retrieved via MORVS 2026-10-25 from https://api.morvs.ai/clinical/NCT00395395. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
